Latent TB (LTBI) treatment: Challenges in India with an eye on 2025: "To Treat LTBI or not to treat, that is the question"
- PMID: 33308671
- DOI: 10.1016/j.ijtb.2020.09.028
Latent TB (LTBI) treatment: Challenges in India with an eye on 2025: "To Treat LTBI or not to treat, that is the question"
Abstract
Latent tuberculosis infection (LTBI) is defined as a consistent immune response to Mycobacterium tuberculosis antigens without evidence of clinically evident active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations especially in high prevalent country like India. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI. Therefore an unequivocal policy /of diagnosis and treatment of LTBI will serve to ameliorate the standards of the Indian health scenario and bring the TB infection to the propinquity of its ultimate elimination.
Keywords: India; Latent; TB Infection.
Copyright © 2020. Published by Elsevier B.V.
Conflict of interest statement
Conflicts of interest The authors have none to declare.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
